Menu
Not yet recruiting NCT07015827

Effect of Locally Produced Mango Variety on Glycemic Index

No phase Interventional Glycemic Index and Glycemic Load

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mango (langra), mango (chaunsa), MANGO (SINDHRI).
Who it may be relevant to
Registry conditions: Glycemic Index and Glycemic Load. Basic parameters: 18 years — 30 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.

Detailed description

This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.

Interventions

  • Other Mango (langra)
    Participants will consume mango variety A . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.
  • Other mango (chaunsa)
    Participants will consume mango variety B . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.
  • Other MANGO (SINDHRI)
    Participants will consume mango variety C . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.

Primary outcome measures

  • Glycemic Index (GI) of Mango Varieties [Time frame: 0 to 120 minutes after consumption of test food]
Secondary outcome measures (1)
  • Peak Blood Glucose Level [Time frame: 0 to 120 minutes after consumption]

Eligibility criteria

Inclusion criteria

  • Healthy non-diabetic adults
  • Normal fasting blood glucose levels
  • Willingness to provide informed consent

Exclusion criteria

Diagnosis of diabetes mellitus or impaired glucose tolerance

  • Gastrointestinal, metabolic, or endocrine disorders
  • Current use of medications affecting blood glucose
  • Pregnant or lactating women
  • Smoking or alcohol consumption

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07015827 · GL/GI-NA_1V1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗